Abstract
Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis, dysplasia and peripheral cytopenias. Nowadays, MDS therapy is selected......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
